AdAlta Limited (1AD.AX) News
Track canonical SquawkNews coverage tagged to 1AD.AX, AdAlta Limited. This hub brings together deduplicated headlines about asx, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BUZZ — Australia's AdAlta surges as partner lands up to $120 million cell therapy deal
* Shares of AdAlta rise as much as 33.3% to A$0.0040, marking their biggest intraday pct gain since September 3 * Shares hit their highest level since September 4 * Biotech firm says its cell therapy manufacturing partne
EQUITY | Sep 18, 2026, 01:52 AM UTC
L
BRIEF — Adalta Says Oribiotech Deal Validates Adalta Manufacturing Strategy
Sept 18 (Reuters) — Adalta Ltd: Oribiotech Deal Validates Adalta Manufacturing Strategy Oribiotech Signs 10-year Partnership Worth Up To $120 Million For Iro Platform Further company coverage: 1AD.AX (Reuters.Briefs@thom
NEWS | Sep 18, 2026, 01:02 AM UTC